Skip to content
MarketScale
‹ Back to IndustriesSciences

SUPPLEMENT DELIVERY FORMS CAN BE AS IMPORTANT AS THE SUPPLEMENT ITSELF

Now that you have the perfect formula to add to your product line, what dosage form should you choose for delivery? Capsules, tablets, softgels, powder or liquid? During the development process for a new dietary supplement, besides the choice of active ingredients, it’s important to consider the final dosage form. The dosage form is not…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Promoted Content · Promoted Content
Share
SUPPLEMENT DELIVERY FORMS CAN BE AS IMPORTANT AS THE SUPPLEMENT ITSELF

Key takeaways

01

Now that you have the perfect formula to add to your product line, what dosage form should you choose for delivery?

02

Capsules, tablets, softgels, powder or liquid?

03

During the development process for a new dietary supplement, besides the choice of active ingredients, it’s important to consider the final dosage form.

Now that you have the perfect formula to add to your product line, what dosage form should you choose for delivery? Capsules, tablets, softgels, powder or liquid? During the development process for a new dietary supplement, besides the choice of active ingredients, it’s important to consider the final dosage form. The dosage form is not only important for how the product will ultimately be presented to the consumer but also may have critical influence on the formulation itself due to technical, efficacy and shelf life constraints.

Fortunately, there are a variety of dosage delivery options across supplements and plenty of new technologies and trends in the industry.

Powders and Liquids: Mixing it Up

Traditional forms such as tablets and capsules along with powders and liquids require different packaging and storage conditions to deliver safe and efficacious products while still appealing to shifting consumer trends. When deciding which supplements are best suited to an individual’s needs, in addition to overall product quality, it is essential to consider how delivery form may impact usability, stability and shelf life.

Otherwise, you end up with products that harden, oxidize, taste bad, mix badly, change color, or even become rancid. Certain ingredients, for example, mix best in powder form. Protein or other nutrients that do not require exact measurements are especially well-suited to powder formulas.

The downside is that powder sitting in water over time can cause microbial growth, making it dangerous to consume. Liquids are another option, especially for a quick, no-hassle way to take a supplement. However, liquid formulations limit the amount of active material available in a serving and are not ideal for bad-tasting substances. Popular dosage forms are diverse and expanding with consumer preference.

Tablets, Capsules, and Softgels: All in Good Taste

Capsules are perfect for almost any product needing a highly precise dosage measurement or for those with a bad taste. Tablets can also deliver a precisely measured dose and offer a similar breakdown time to capsules: about 20 minutes. However, it is possible to scientifically manipulate dissolution time by coating capsules in ingredients targeted to certain delivery specifications.

Softgels offer an effective delivery form for liquid or oil-based formulas. Available in different sizes and colors, the contents are typically suspended in oils, making softgels and ideal delivery form for lipid- and fat-soluble nutrients such as efficacious oils, fatty acids, fat-soluble extracts or fat-soluble lettered vitamins. Innovative capsule-in-capsule technology makes it possible to combine both powders and liquids into a single dosage form, creating new opportunities to have incompatible ingredients play well together to deliver added benefits not previously possible.

Powders in Stick Packs: Easy-to-Swallow Innovations

Powders in stick packs, or sachets, are gaining popularity. These new technologies have been developed partly in response to issues of swallowability. Other dosage forms or delivery systems are seeing increasing interest to avoid the “pill fatigue” issue that seems to be trending. Powders in Stick Packs and liquids in “shots” seem to be gaining ground in the market due to their convenience and portability for today’s on-the-go lifestyle.

Important Considerations for Supplement Dosage Forms

Quality will always be a key consideration in choosing wellness supplements. However, efficacy and bioavailability are critical as well. Depending on the dosage form, one may have to rethink formulation requirements to accommodate the attributes needed. For example, flow and compaction characteristics, particle size and solubility all must fit the purpose for solid dosage forms. Add to those taste and appearance characteristics for those forms that will be consumed in powder or liquid forms and formulation issues can become much more complicated. Shelf life requirements are also a major consideration that should not be overlooked in the choice of ingredients, dosage form and packaging format. After all, the best ingredients in the best dosage form hold little value to the consumer if they do not deliver the best quality and efficacy at the stated expiration date on the label.

As a start-to-finish provider, Deerland Probiotics & Enzymes delivers contract manufacturing services for science-backed enzyme and probiotic-based formulations. Learn more here about the manufacturing capabilities of Deerland Probiotics & Enzymes.

About the author

PC
Promoted Content

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

The pharmaceutical industry is facing a significant challenge as over $300 billion in branded pharmaceutical revenue is set to lose patent protection by 2030. This revenue gap is driving the largest merger and acquisition cycle seen in a decade, with companies seeking external growth through acquisitions. This shift is impacting the entire life sciences supply chain, prompting strategic changes across the industry.

  • 01Over $300 billion in pharmaceutical revenue is at risk due to patent expirations by 2030.
  • 02Big Pharma is engaging in an aggressive cycle of mergers and acquisitions.
  • 03The acquisitions are reshaping the life sciences supply chain.

Jun 29, 2026

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic

Quotient Sciences has initiated a Phase I clinical study of an oral solid dose formulation designed using AI, cleared by the UK's MHRA and conducted at the company's UK facility. The trial—built on machine learning algorithms from partner Intrepid Labs and Quotient's Translational Pharmaceutics platform—aims to validate AI as a direct contributor to formulation design rather than just an upstream analytical tool. Benchling characterizes the broader moment as biotech entering a "builder phase," in which leading organizations embed AI capability at the bench level rather than running isolated pilots.

  • 01Quotient Sciences has dosed healthy volunteers in a Phase I study it describes as the first clinical evaluation of an AI-designed oral formulation, following approval from the UK's MHRA.
  • 02The formulation was developed using advanced machine learning algorithms from Intrepid Labs, integrated with Quotient Sciences' Translational Pharmaceutics platform.
  • 03Benchling identifies a sector-wide shift toward embedding AI capability directly at the bench, moving beyond isolated pilots to structural adoption across biotech R&D.

Jun 17, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

PC
Promoted Content

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512